Global and United States Microbiology Testing/Clinical Microbiology Market Report & Forecast 2022-2028

SKU ID : QYR-20575975 | Publishing Date : 24-Mar-2022 | No. of pages : 96

Key factors driving the growth of this market include ongoing technological advancements in the field of infectious disease diagnosis, rising incidence of infectious diseases and growing outbreak of epidemics, and increased funding and public-private investments for research and innovation.
Market Analysis and Insights: Global and United States Microbiology Testing/Clinical Microbiology Market
This report focuses on global and United States Microbiology Testing/Clinical Microbiology market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Microbiology Testing/Clinical Microbiology market size is estimated to be worth US$ 3360.8 million in 2022 and is forecast to a readjusted size of US$ 4401.9 million by 2028 with a CAGR of 4.6% during the review period. Fully considering the economic change by this health crisis, by Type, Cell Culture accounting for % of the Microbiology Testing/Clinical Microbiology global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Hospital Labs was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
North America is expected to hold the largest share of the global clinical microbiology market in 2018, however, Asia Pacific is expected to grow at the fastest rate during the forecast period.
Global Microbiology Testing/Clinical Microbiology Scope and Market Size
Microbiology Testing/Clinical Microbiology market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Microbiology Testing/Clinical Microbiology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Microbiology Testing/Clinical Microbiology market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Cell Culture
Microscopy
Serology
Segment by Application
Hospital Labs
Pathology Labs
Research Institutes
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Biomerieux
Danaher
Becton, Dickinson
Abbott Laboratories
Roche Diagnostics
Bruker
Hologic
Bio-Rad Laboratories
Qiagen
Thermo Fisher Scientific
Agilent
Merck Kgaa
3M
Neogen

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
  • By product type
  • By End User/Applications
  • By Technology
  • By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
PRICE
4350
8700

5075


  • market Reports market Reports